
American Oncology Network Appoints New Board of Managers Members, Announces Resignation of Two Members

AON celebrates its Board of Managers’ appointments and retirements.
“We are pleased to welcome both Dr. Divers and Dr. Wright-Browne to our board,” said AON Chief Executive Officer
Dr. Divers received his medical degree from Louisiana State University, completed an internal medicine residency at the University of North Carolina at Chapel Hill and then attended an oncology-hematology fellowship at the University of Alabama. Currently, he is a medical oncologist at AON’s partner practice
“I am honored to be selected to join the AON Board of Managers,” said Divers. “I am passionate about community oncology and being part of an organization such as AON that works hard to preserve community oncology is a rewarding experience.”
Dr. Wright-Browne received her medical degree from the University of West Indies, completed a residency program at the University of Connecticut and then attended an oncology-hematology fellowship at the University of Texas MD Anderson Cancer Center. She is Board certified in medical oncology and hematology. She practices at the
“Throughout my career, I have had the opportunity to help many people through their cancer journeys,” said Wright-Browne. “I am eager to continue serving cancer patients in a new way by joining AON’s Board of Managers.”
Effective January 1, Stephen Orman, MD, and Daniel Spitz, MD, retired from their roles on the Board of Managers. Dr. Orman and Dr. Spitz had served on the Board of Managers since AON’s founding in 2018.
“We are greatly appreciative to Dr. Orman and Dr. Spitz for their dedication to helping AON grow in the early years and positioning the organization for expansion,” said Schonherz. “They have been incredibly valuable advisors, and on behalf of the organization, we thank them and wish them well.”
For more information about AON and its executive board, visit
###
About American Oncology Network, LLC
The
SOURCE: American Oncology Network, LLC
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.